Branhamella catarrhalis: Epidemiology, surface antigenic structure, and immune response

Microbiological Reviews

Volumn 60, Issue 2, 1996, Pages 267-279

  Murphy, Timothy F ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b VA WESTERN NEW YORK HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; OUTER MEMBRANE PROTEIN;

ANTIBODY RESPONSE; ANTIGEN DETECTION; BACTERIAL COLONIZATION; BACTERIAL OUTER MEMBRANE; BACTERIUM ISOLATION; BACTERIUM PILUS; HOST RESISTANCE; HUMAN; LOWER RESPIRATORY TRACT INFECTION; MORAXELLA CATARRHALIS; NONHUMAN; OTITIS MEDIA; REVIEW; TAXONOMY;

EID: 0029904385     PISSN: 01460749     EISSN: None     Source Type: Journal    
DOI: 10.1128/mmbr.60.2.267-279.1996     Document Type: Review

References (187)

1. Ahmad, F., D. T. McLeod, J. T. Power, and M. A. Calder. 1985. Branhamella catarrhalis prevalence in a hospital population. J. Hosp. Infect. 6:71-74.
2. Ahmed, K. 1992. Fimbriae of Branhamella catarrhalis as possible mediators of adherence to pharyngeal epithelial cells. APMIS 100:1066-1072.
3. Ahmed, K., H. Masaki, T. C. Dai, A. Ichinose, Y. Utsunomiya, M. Tao, T. Nagatake, and K. Matsumoto. 1994. Expression of fimbriae and host response in Branhamella catarrhalis respiratory infections. Microbiol. Immunol. 38:767-771.
4. Ahmed, K., N. Rikitomi, A. Ichinose, and K. Matsumoto. 1991. Possible presence of a capsule in Branhamella catarrhalis. Microbiol. Immunol. 35: 361-366.
5. Ahmed, K., N. Rikitomi, and K. Matsumoto. 1992. Fimbriation, hemagglutination and adherence properties of fresh clinical isolates of Branhamella catarrhalis. Microbiol. Immunol. 36:1009-1017.
6. Ahmed, K., N. Rikitomi, T. Nagatake, and K. Matsumoto. 1990. Electron microscopic observation of Branhamella catarrhalis. Microbiol. Immunol. 34:967-975.
7. Aitken, J. M., and P. E. Thornley. 1983. Isolation of Branhamella catarrhalis from sputum and tracheal aspirate. J. Clin. Microbiol. 18:1262-1263.
8. Alaeus, A., and G. Stiernstedt. 1991. Branhamella catarrhalis septicemia in an immunocompetent adult. Scand. J. Infect. Dis. 23:115-116.
9. Aniansson, G., B. Aim, B. Andersson, P. Larsson, O. Nylen, H. Peterson, P. Rigner, M. Svanborg, and C. Svanborg. 1992. Nasopharyngeal colonization during the first year of life. J. Infect. Dis. 165(Suppl. 1):S38-S42.
10. Aspin, M. M., A. Hoberman, J. McCarty, S. E. McLinn, S. Aronoff, D. J. Lang, and A. Arrieta. 1994. Comparative study of the safety and efficacy of clarithromycin and amoxicillin-clavulanate in the treatment of acute otitis media in children. J. Pediatr. 125:135-141.
11. Barenkamp, S. J. 1986. Protection by serum antibodies in experimental nontypable Haemophilus influenzae otitis media. Infect. Immun. 52:572-578.
12. Bartos, L. C., and T. F. Murphy. 1988. Comparison of the outer membrane proteins of 50 strains of Branhamella catarrhalis. J. Infect. Dis. 158:761-765.
13. Beaulieu, D., S. Scriver, M. G. Bergeron, D. E. Low, T. R. Parr, Jr., J. E. Patterson, A. Matlow, and P. H. Roy. 1993. Epidemiological typing of Moraxella catarrhalis by using DNA probes. J. Clin. Microbiol. 31:736-739.
14. Beucher, M., and P. F. Sparling. 1995. Cloning, sequencing, and characterization of the gene encoding FrpB, a major iron-regulated, outer membrane protein of Neisseria gonorrhoeae. J. Bacteriol. 177:2041-2049.
15. Bhushan, R., R. Craigie, and T. F. Murphy. 1994. Molecular cloning and characterization of outer membrane protein E of Moraxella (Branhamella) catarrhalis. J. Bacteriol. 176:6636-6643.
16. Bhushan, R., J. M. Surface, E. Denardin, and T. F. Murphy. Antigenic characterization of outer membrane protein E of Moraxella (Branhamella) catarrhalis. Submitted for publication.
17. Bisno, A. L. 1995. Streptococcus pyogenes, p. 1786-1798. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.). Principles and practice of infectious diseases. Churchill Livingstone, New York.
18. Black, A. J., and T. S. Wilson. 1988. Immunoglobulin G (IgG) serological response to Branhamella catarrhalis in patients with acute bronchopulmonary infections. J. Clin. Pathol. 41:329-333.
19. Bovre, K. 1979. Proposal to divide the genus Moraxella into two subgenera, subgenus Moraxella and subgenus Branhamella. Int. J. Syst. Bacteriol. 29:403-406.
20. Boyle, F. M., P. R. Georghiou, M. H. Tilse, and J. G. McCormack. 1991. Branhamella (Moraxella) catarrhalis: pathogenic significance in respiratory infections. Med. J. Aust. 154:592-596.
21. Brorson, J.-E., A. Axelsson, and S. E. Holm. 1976. Studies on Branhamella catarrhalis (Neisseria catarrhalis) with special reference to maxillary sinusitis. Scand. J. Infect. Dis. 8:151-155.
22. Brunham, R. C., F. A. Plummer, and R. S. Stephens. 1993. Bacterial antigenic variation, host immune response, and pathogen-host coevolution. Infect. Immun. 61:2273-2276.
23. Burman, L. A., M. Leinonen, and B. Trollfors. 1994. Use of serology to diagnose pneumonia caused by nonencapsulated Haemophilus influenzae and Moraxella catarrhalis. J. Infect. Dis. 170:220-222.
24. Campagnari, A. A., T. F. Ducey, and C. A. Rebmann. OMP B1, an iron-repressible protein conserved in the outer membrane of Moraxella (Branhamella) catarrhalis, binds human transferrin. Submitted for publication.
25. Campagnari, A. A., M. R. Gupta, K. C. Dudas, T. F. Murphy, and M. A. Apicella. 1987. Antigenic diversity of lipooligosaccharides of nontypeable Haemophilus influenzae. Infect. Immun. 55:882-887.
26. Campagnari, A. A., K. L. Shanks, and D. W. Dyer. 1994. Growth of Moraxella catarrhalis with human transferrin and lactoferrin: expression of iron-repressible proteins without siderophore production. Infect. Immun. 62: 4909-4914.
27. Campagnari, A. A., S. M. Spinola, A. J. Lesse, Y. Abu Kwaik, R. E. Mandrell, and M. A. Apicella. 1990. Lipooligosaccharide epitopes shared among gram-negative nonenteric mucosal pathogens. Microb. Pathog. 8:353-362.
28. Carson, R. T., D. F. McDonald, M. A. Kehoe, and J. E. Calvert. 1994. Influence of Gm allotype on the IgG subclass response to streptococcal M protein and outer membrane proteins of Moraxella catarrhalis. Immunology 84:107-113.
29. Catlin, B. W. 1970. Transfer of the organism named Neisseria catarrhalis to Branhamella genus. Int. J. Syst. Bacteriol. 20:155-159.
30. Catlin, B. W. 1990. Branhamella catarrhalis: an organism gaining respect as a pathogen. Clin. Microbiol. Rev. 3:293-320.
31. Catlin, B. W. 1991. Branhamaceae fam. nov., a proposed family to accommodate the genera Branhamella and Moraxella. Int. J. Syst. Bacteriol 41: 320-323.
32. Chapman, A. J., D. M. Musher, S. Jonsson, J. E. Clarridge, and R. J. Wallace. 1985. Development of bactericidal antibody during Branhamella catarrhalis infection. J. Infect. Dis 151:878-882.
33. Chonmaitree, T., M. J. Owen, J. A. Patel, D. Hedgpeth, D. Horlick, and V. M. Howie. 1992. Effect of viral respiratory tract infection on outcome of acute otitis media. J. Pediatr. 120:856-862.
34. Choo, P. W., and N. M. Gantz. 1989. Branhamella catarrhalis pneumonia, with bacteremia. South. Med. J. 82:1317-1318.
35. Chung, M.-H., R. Enrique, D. J. Lim, and T. F. DeMaria. 1994. Moraxella (Branhamella) catarrhalis-induced experimental otitis media in the chinchilla. Acta Otolaryngol. 114:415-422.
36. Cimolai, N., and R. J. Adderley. 1989. Branhamella catarrhalis bacteremia in children. Acta Paediatr. Scand. 78:465-468.
37. Collazos, J., J. de Miguel, and R. Ayarza. 1992. Moraxella catarrhalis bacteremic pneumonia in adults: two cases and review of the literature. Eur J Clin. Microbiol. Infect. Dis. 11:237-240.
38. Contreras, M. R., S. R. Ash, S. D. Swick, and J. Grutzner. 1993. Peritonitis due to Moraxella (Branhamella) catarrhalis in a diabetic patient receving peritoneal dialysis. South. Med. J. 86:589-590.
39. Cook, P. P., D. W. Hecht, and D. R. Snydman. 1989. Nosocomial Branhamella catarrhalis in a paediatric intensive care unit: risk factors for disease J. Hosp. Infect. 13:299-307.
40. Cooke, R. P. D., R. Williams, and C. M. Bannister. 1990. Shunt-associated ventriculitis caused by Branhamella catarrhalis. J. Hosp. Infect. 15:197-198.
41. Craig, D. B., and P. A. Wehrle. 1983. Branhamella catarrhalis septic arthritis. J. Rheumatol. 10:985-986.
42. Davies, B. I., and F. P. V. Maesen. 1986. Epidemiological and bacteriological findings on Branhamella catarrhalis respiratory infections in The Netherlands. Drugs 31(3):28-33.
43. DelBeccaro, M. A-, P. M. Mendelman, A. F. Inglis, M. A. Richardson, N. O, Duncan, C. R. Clausen, and T. L. Stall. 1992. Bacteriology of acute otitis media: a new perspective. J. Pediatr. 120:81-84.
44. Denamur, E., N. Picard-Pasquier, C. Mura, B. Picard, J. Orfila, and B. Krishnamoorthy. 1991. Comparison of molecular epidemiological tools for Branhamella catarrhalis typing. Res. Microbiol. 142:585-589.
45. Dickinson, D. P., B. G. Loos, D. M. Dryja, and J. M. Bernstein. 1988. Restriction fragment mapping of Branhamella catarrhalis: a new tool for studying the epidemiology of this middle ear pathogen. J. Infect. Dis. 158:205-208.
46. Doern, G. V., and N. M. Gantz. 1982. Isolation of Branhamella (Neosseria) catarrhalis from men with urethritis. Sex. Transm. Dis. 9:202-204.
47. Doern, G. V., M. J. Miller, and R. E. Winn. 1981. Branhamella (Neisseria) catarrhalis systemic disease in humans. Arch. Intern. Med. 141:1690-1691
48. Douer, D., Y. Danziger, and J. Pinkhas. 1977. Neisseria catarrhalis endocarditis. Ann. Intern. Med. 86:116.
49. Doyle, W. J. 1989. Animal models of otitis media: other pathogens. Pediatr. Infect. Dis. J. 8:S45-S47.
50. Dyson, C., H. D. Poonyth, M. Watkinson, and S. J. Rose. 1990. Life threatening Branhamella catarrhalis pneumonia in young infants. J. Infect. 21:305-307.
51. Edebrink, P., P.-E. Jansson, M. M. Rahman, G. Widmalm, T. Holme, M. Rahman, and A. Weintraub. 1994. Structural studies of the O-polysaccharide from the lipopolysaccharide of Moraxella (Branhamella) catarrhalis serotype A (strain ATCC 25238). Carbohydr. Res. 257:269-284.
52. Ejlertsen, T., E. Thisted, F. Ebbesen, B. Olesen, and J. Renneberg. 1994. Branhamella catarrhalis in children and adults. A study of prevalence, time of colonisation, and association with upper and lower respiratory tract infections. J. Infect. 29:23-31.
53. Eliasson, I. 1986. Serological identification of Branhamella catarrhalis: serological evidence for infection. Drugs 31(3):7-10.
54. Engleberg, N. C, E. Pearlman, and B. I. Eisenstein. 1984. Legionella pneumophila surface antigens cloned and expressed in Escherichia coli are translocated to the host cell surface and interact with specific anti-Legionella antibodies. J. Bacteriol. 160:199-203.
55. Faden, H., J. Bernstein, L. Brodsky, J. Stanievich, D. Drystofik, C. Shuff, J. J. Hong, and P. L. Ogra. 1989. Otitis media in children. I. The systemic immune response to nontypable Haemophilus influenzae. J. Infect. Dis. 160:999-1004.
56. Faden, H., J. Bernstein, J. Stanievich, L. Brodsky, and P. L. Ogra. 1992. Effect of prior antibiotic treatment on middle ear disease in children. Ann. Otol. Rhinol. Laryngol. 101:87-91.
57. Faden, H., L. Brodsky, M. J. Waz, J. Stanievich, J. Bernstein, and P. L, Ogra. 1991. Nasopharyngeal flora in the first three years of life in normal and otitis-prone children. Ann. Otol. Rhinol. Laryngol. 100:612-615.
58. Faden, H., Y. Harabuchi, J. J. Hong, and Tonawanda/Williamsville Pediatrics. 1994. Epidemiology of Moraxella catarrhalis in children during the first 2 years of life: relationship to otitis media. J. Infect. Dis. 169:1312-1317.
59. Faden, H., J. Hong, and T. F. Murphy. 1992. Immune response 10 outer membrane antigens of Moraxella catarrhalis in children with otitis media. Infect. Immun. 60:3824-3829.
60. Faden, H., J. J- Hong, and N. Pahade. 1994. Immune response to Moraxella catarrhalis in children with otitis media: opsonophagocytosis with antigen-coated latex beads, Ann. Otol. Rhinol. Laryngol. 103:522-524.
61. Fomsgaard, J. S., A. Fomsgaard, N. Hoiby, B. Bruun, and C. Galanos. 1991. Comparative immunochemistry of lipopolysaccharides from Branhamella catarrhalis strains. Infect. Immun. 59:3346-3349.
62. Forsgren, A., A. Penta, S. F. Schlossman, and T. F. Tedder. 1988. Branhamella catarrhalis activates human B lymphocytes following interactions with surface IgD and class I major histocompatibility complex antigens. Cell. Immunof 112:78-88.
63. Can, V. N.. H. Kusmiesz, S. Shelton, and J. D. Nelson. 1991. Comparative evaluation of loracarbef and amoxicillin-clavulanate for acute otitis media. Antimicrob. Agents Chemother. 35:967-971.
64. Gehanno, P., P. Berche, I. Boucot, N. Lambert-Zechovsky, E. Bingen, J. J. Gres. and C. Rollin. 1994. Comparative efficacy and safety of cefprozil and amoxicillin-clavulanate in the treatment of acute otitis media in children. J. Antimicrob. Chemother. 33:1209-1218.
65. Gnon, A., and H. Pfeiffer. 1902. Der Micrococcus catarrhalis (R. Pfeiffer) als Krankheitserreger. Z. Klin. Med. 44:263-281.
66. Giebink, G. S., I. K. Berzins, and S. C. Marker. 1980. Experimental otitis media after nasal inoculation of Streptococcus pneumoniae and influenza A virus in chinchillas. Infect. Immun. 30:445-450.
67. Giebink, G. S., I. K. Berzins, G. Schiffman, and P. G. Quie. 1979. Experimental otitis media in chinchillas following nasal colonization with type 7F Stretococcus pneumoniae: prevention after vaccination with pneumococcal capsular polysaccharide. J. Infect. Dis. 140:716-723.
68. Gilleland, H. E., Jr., L. B. Gilleland, and J. M. Matthews-Greer. 1988. Outer membrane protein F preparation of Pseudomonas aeruginosa as a vaccine against chronic pulmonary infection with heterologous immunotype strains in a rat model. Infect. Immun. 56:1017-1022.
69. Gilleland, H. E., Jr., M. G. Parker, J. M. Matthews, and R. D. Berg. 1984. Use ot a purified outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine in mice. Infect. Immun. 44:49-54.
70. Goldblatt, D., G. K. Scadding, V. J. Lund, A. M. Wade, M. W. Turner, and J. P. Pandey. 1994. Association of Gm allorypes with the antibody response to the outer membrane proteins of a common upper respiratory tract organism. Moraxella catarrhalis. J. Immunol. 153:5316-5320.
71. Goldblatt, D., M. W. Turner, and R. J. Levinsky. 1990. Branhamella catarrhalis: antigenic determinants and the development of the IgG subclass response in childhood. J. Infect. Dis. 162:1128-1135.
72. Goldshneider, I., E. C. Gotschlich, and M. S. Artenstein. 1969. Human immunity to the meningococcus. I. The role of humoral antibody. J. Exp. Med. 129:1307-1326.
73. Gray. L. D., R. E. Van Scoy, J. P. Anhalt, and P. K. W. Yu. 1989. Wound infection caused by Branhamella catarrhalis. J. Clin. Microbiol. 27:818-820.
74. Green, B. A., M. E. Vazquez. G. W. Zlotnick, G. Quigley-Reape, J. D. Swarts, I. Green, J. L. Cowell, C. D. Bluestone, and W. J. Doyle. 1993. Evaluation of mixtures of purified Haemophilus influenzue outer membrane proteins in protection against challenge with nontypeable H. influenzue in the chinchilla otitis media model. Infect. Immun. 61:1950-1957.
75. Gulig, P. A., G. H. McCracken, Jr., C. F. Frisch, K. H. Johnston, and E. J. Hansen. 1982. Antibody response of infants to cell surface-exposed outer membrane proteins of Haemophilus influenzae type b after systemic Haemophilia disease. Infect. Immun. 37:82-88.
76. Guthrie, R., K. Bakenhaster, R. Nelson, and R. Woskobnick. 1988. Branhamella catarrhalis sepsis: a case report and review of the literature. J. Infect. Dis. 158:907-908.
77. Haase, E. M., A. A. Campagnari, J. Sarwar, M. Shero, M. Wirth, C. U. Cumming, and T. F. Murphy. 1991. Strain-specific and immunodominant surface epitopes of the P2 porin protein of nontypeable Haemophilus influenzae. Infect. Immun. 59:1278-1284.
78. Haase, E. M., K. Yi, G. D. Morse, and T. F. Murphy. 1994. Mapping of bactericidal epitopes on the P2 porin protein of nontypeable Haemophilus influenzae. Infect. Immun. 62:3712-3722.
79. Haddad, J., A. Le Faou, U. Simeoni, and J. Messer. 1986. Hospital-acquired bronchopulmonary infection in premature infants due to Branhamella catarrhalis. J. Hosp. Infect. 7:301-302.
80. Hager, H., A. Verghese, S. Alvarez, and S. L. Berk. 1987. Branhamella catarrhalis respiratory infections. Rev. Infect. Dis. 9:1140-1149.
81. Harkness, R. E., M.-J. Guimond, B.-A. McBey, M. H. Klein, D. H. Percy, and B. A. Croy. 1993. Branhamella catarrhalis pathogenesis in SCID and SCID beige mice. APMIS 101:805-810.
82. Hellio, R., M. Guibourdenche, E. Collatz, and J. Y. Riou. 1988. The envelope structure of Branhamella catarrhalis as studied by transmission electron microscopy. Ann. Inst. Pasteur (Paris) 139:515-525.
83. Helminen, M. E., I. Maciver, J. L. Latimer, L. D. Cope, G. H. McCracken, Jr., and E. J. Hansen. 1993. A major outer membrane protein of Moraxella catarrhalis is a target for antibodies that enhance pulmonary clearance of the pathogen in an animal model. Infect. Immun. 61:2003-2010.
84. Helminen, M. E., I. Maciver, J. L. Latimer, J. Klesney-Tait, L. D. Cope, M. Paris, G. H. McCracken, Jr., and E. J. Hansen. 1994. A large, antigenically conserved protein on the surface of Moraxellu calarrhalis is a target for protective antibodies. J. Infect. Dis. 170:867-872.
85. Helminen, M. E., I. Maciver, M. Paris, J. L. Latimer, S. L. Lumbley, L. D. Cope, G. H. McCracken, Jr., and E. J. Hansen. 1993. A mutation affecting expression of a major outer membrane protein of Moraxella catarrhalis alters serum resistance and survival in vivo. J. Infect. Dis. 168:1194-1201.
86. Hiroshi, S., E. J. Anaissie, N. Khardori, and G. P. Bodey. 1988. Branhamella catarrhalis septicemia in patients with leukemia. Cancer 61:2315-2317.
87. Hol, C, C. M. Verduin, E. Van Dijk, J. Verhoef, and H. Van Dijk. 1993. Complement resistance in Branhamella (Moraxella) catarrhalis. Lancet 341:1281.
88. Hsiao, C. B., S. Sethi, and T. F. Murphy. 1995. Outer membrane protein CD of Branhamella catarrhalis: sequence conservation in strains recovered from the human respiratory tract. Microb. Pathog. 19:215-225.
89. Ikram, R. B., M. Nixon, J. Aitken, and E. Wells. 1993. A prospective study of isolation of Moraxella catarrhalis in a hospital during the winter months. J. Hosp. Infect. 25:7-14.
90. Ioannidis, J. P. A., M. Worthington, J. K. Griffiths, and O. R. Snydman. 1995. Spectrum and significance of bacteremia due to Moraxella catarrhalis. Clin. Infect. Dis. 21:390-397.
91. Jeanteur, D., J. H. Lakey, and F. Pattus. 1991. The bacterial porin super-family: sequence alignment and structure prediction. Mol. Microbiol. 5:2153-2164.
92. Johnson, C. E., S. A. Carlin, D. M. Super, J. M. Rehmus, D. G. Roberts, N. C. Christopher, J. K. Whitwell, and P. A. Shurin. 1991. Ceframe compared with amoxicillin for treatment of acute otitis media. J. Pediatr. 119:117-122.
93. Jonsson, I., T. Holme, A. Krook, and M. Thoren. 1993. Serological cross-reactions between Moraxella (Branhamella) catarrhalis and oropharyngeal bacteria. Eur. J. Clin. Microbiol. Infect. Dis. 12:289-293.
94. Jordan, K. L., S. H. Berk, and S. L. Berk. 1990. A comparison of serum bactericidal activity and phenotypic characteristics of bacteremic, pneumonia-causing strains, and colonizing strains of Branhamella catarrhalis. Am. J. Med. 88(Suppl. 5A):28S-32S.
95. Jousimies-Somer, H. R., S. Savolainen, and J. S. Ylikoski. 1989. Comparison of the nasal bacterial floras in two groups of healthy subjects and in patients with acute maxillary sinusitis. J. Clin. Microbiol. 27:2736-2743.
96. Karjalainen, H., M. Koskela, J. Luotonen, E. Herva, and P. Sipila. 1991. Occurrences of antibodies against Streptococcus pneumonias, Haemophilus influenzae and Branhamella catarrhalis in middle ear effusion and serum during the course of acute otitis media. Acta Otolaryngol. 111:112-119.
97. Karjalainen, H., M. Koskela, J. Luotonen, and P. Sipila. 1991. Secretory antibodies specitic to Streptococcus pneumoniae, Haemophilus influenzae and Branhamella catarrhalis in middle ear effusion during acute otitis media. Acta Otolaryngol. 111:524-529.
98. Kawakami, Y., K. Segawa, and M. Kandi. 1983. A case of acute catarrhal conjunctivitis due to Branhamella catarrhalis. Microbiol. Immunol. 27:641-642.
99. Kawakami, Y., I. Ueno, T. Katsuyama, K. Furihata, and H. Matsumoto. 1994. Restriction fragment length polymorphism (RFLP) of genomic DNA of Moraxella (Branhamella) catarrhalis isolates in a hospital. Microbiol. Immunol. 38:891-895.
100. Klein, J. O. 1994. Otitis media. Clin. Infect. Dis. 19:823-833.
101. Klingman, K. L., and T. F. Murphy. 1994. Purification and characterization of a high-molecular-weight outer membrane protein of Moraxella (Branhamella) catarrhalis. Infect. Immun. 62:1150-1155.
102. Klingman, K. L., A. Pye, T. F. Murphy, and S. L. Hill. 1995. Dynamics of respiratory tract colonization by Moraxella (Branhamella) catarrhalis in bronchiectasis. Am. J. Respir. Crit. Care Med. 152:1072-1078.
103. Korppi, M., M. L. Katila, J. Jaaskalainen, and M. Leinonen. 1992. Role of Moraxella (Branhamella) catarrhalis as a respiratory pathogen in children, Acta Paediatr. 81:993-996.
104. Kostiala, A. A. I., and T. Honkanen. 1989. Branhamella catarrhalis as a cause of acute purulent pericarditis. J. Infect. 19:291-292.
105. Lancefield, R. C. 1933. A serological differentiation of human and other groups of hemolytic streptococci. J. Exp. Med. 57:571-595.
106. Lancefield, R. C. 1962. Current knowledge of type specific M antigens of group A streptococci. J. Immunol. 89:307-313.
107. Leach, A. J., J. B. Boswell, V. Asche, T. G. Nienhuys, and J. D. Mathews. 1994. Bacterial colonization of the nasopharynx predicts very early onset and persistence of otitis media in Australian Aboriginal infants. Pediatr. Infect. Dis. J. 13:983-989.
108. Leinonen, M., J. Luotonen, E. Herva, K. Valkonen, and P. H. Makela. 1981. Preliminary serologic evidence for a pathogenic role of Branhamella catarrhalis. J. Infect. Dis. 144:570-574.
109. Loeb, M. R. 1984. Immunoblot method for identifying surface components, determining their cross-reactivity, and investigating cell topology: results with Haemophilus influenzae type b. Anal. Biochem. 143:196-204.
110. Loeb, M, R., and K. A. Woodin. 1987. Cross-reactivity of surface-exposed epitopes of outer membrane antigens of Haemophilus influenzae type b. Infect. Immun. 55:2977-2982.
111. Lue, Y. A., D. H. Simms, R. Ubriani, N. C. Pfeiffer, and D. S. Gromisch. 1981. Ophthalmia neonatorum caused by penicillin-resistant Branhamella catarrhalis. N. Y. State J. Med. 81:1775-1776.
112. Lundgren, K., and L. Ingvarsson. 1986. Acute otitis media in Sweden. Role of Branhamella catarrhalis and the rationale for choice of antimicrobial therapy. Drugs 31(3):125-131.
113. Maciver, I., M. Unhanand, G. H. McCracken, Jr., and E. J. Hansen. 1993. Effect of immunization on pulmonary clearance of Moraxella catarrhalis in an animal model. J. Infect. Dis. 168:469-472.
114. Marrs, C. F., and S. Weir. 1990. Pili (fimbriae) of Branhamella species. Am. J. Med. 88(Suppl. 5A):36S-45S.
115. Maslow, J. N., M. E. Mulligan, and R. D. Arbeit. 1993. Molecular epidemiology: application of contemporary techniques to the typing of microorganisms. Clin. Infect. Dis. 17:153-164.
116. Masoud, H., M. B. Perry, and J. C. Richards. 1994. Characterization of the lipopolysaccharide of Moraxella catarrhalis. Structural analysis of the lipid A from M. catarrhalis serotype A lipopolysaccharide. Eur. J. Biochem. 220: 209-216.
117. Matthews-Greer, J. M., and H. E. Gilleland, Jr. 1987. Outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine against heterologous immunotype strains in a burned mouse model. J. Infect. Dis. 155:1282-1291.
118. McKenzie, H., M. G. Morgan, J. Z. Jordens, M. C. Enright, and M. Bain. 1992. Characterisation of hospital isolates of Moraxella (Branhamella) catarrhalis by SDS-PAGE of whole-cell proteins, immunoblotting and restriction-endonuclease analysis. J. Med. Microbiol. 37:70-76.
119. McLeod, D. T., F. Ahmad, S. Capewell, M. J. Croughan, M. A. Calder, and A. Seaton. 1986. Increase in bronchopulmonary infection due to Branhamella catarrhalis. Br. Med. J. 292:1103-1105.
120. Melendez, P. R., and R. H. Johnson. 1991. Bacteremia and septic arthritis caused by Moraxella catarrhalis. Rev. Infect. Dis. 13:428-429.
121. Morgan, M. G., H. McKenzie, M. C. Enright, M. Bain, and F. X. S. Emmanuel. 1992. Use of molecular methods to characterize Moraxella catarrhalis strains in a suspected outbreak of nosocomial infection. Eur. J. Clin. Microbiol. Infect. Dis. 11:305-312.
122. Murphy, T. F. Unpublished observations.
123. Murphy, T. F. 1992. Haemophilia, p. 1521-1531. In edited by S. L. Gorbach, J. G. Bartlett, and N. R. Blacklow (ed.). Infectious diseases. The W. B. Saunders Co., Philadelphia.
124. Murphy, T. F., and L. C. Bartos. 1989. Surface-exposed and antigenically conserved determinants of outer membrane proteins of Branhantella catarrhalis. Infect. Immun. 57:2938-2941.
125. Murphy, T. F., C. Kirkham, and A. J. Lesse. 1993. The major heat-modifiable outer membrane protein CD is highly conserved among strains of Branhamella catarrhalis. Mol. Microbiol. 10:87-98.
126. Murphy, T. F., and M. R. Loeh. 1989. Isolation of the outer membrane of Branhamella catarrhalis. Microb. Pathog. 6:159-174.
127. Murphy, T. F., and S. Sethi. 1992. Bacterial infection in chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 146:1067-1083.
128. Newing, W. J., and R. Christie. 1947. Meningitis: isolation of an organism resembling Neisseria catarrhalis from cerebrospinal fluid: report of a case. Med. J. Aust. 1:306.
129. Nicotra, B., M. Rivera, J. I. Luman, and R. J. Wallace. 1986. Branhamella catarrhalis as a lower respiratory tract pathogen in patients with chronic lung disease. Arch. Intern. Med. 146:890-893.
130. Nikaido, H., and M. H. Saier, Jr. 1992. Transport proteins in bacteria: common themes in their design. Science 258:936-942.
131. Ninane, G., J. Joly, and M. Kraytman. 1978. Bronchopulmonary infection due to Branhamella catarrhalis: 11 cases assessed by transtracheal puncture. Br. Med. J. 1:276-278.
132. Noel, G. J., S. J. Barenkamp, J. W. St. Geme III, W. N. Haining, and D. M. Mosser. 1994. High-molecular-weight surface-exposed proteins of Haemophilus influenzas mediate binding to macrophages. J. Infect. Dis. 169: 425-429.
133. Onofrio, J. M., A. N. Shulkin, P. J. Heidbrink, G. B. Toews, and A. K. Pierce. 1981. Pulmonary clearance and phagocytic cell response to normal pharyngeal flora. Am. Rev. Respir. Dis. 123:222-225.
134. Owen, M. J., R. Anwar, H. K. Nguyen, P. R. Swank, E. R. Bannister, and V. M. Howie. 1993. Efficacy of cefixime in the treatment of acute otitis media in children. Am. J. Dis. Child. 147:81-86.
135. Patterson, J. E., T. F. Patterson, P. Farrel, W. J. Hierholzer, Jr., and M. J. Zervos. 1989. Evaluation of restriction endonuclease analysis as an epidemiologic typing system for Branhamella catarrhalis. J. Clin. Microbiol. 27: 944-946.
136. Patterson, T. F., J. E. Patterson, B. L. Masecar, G. E. Barden, W. J. Hierholzer, Jr., and M. J. Zervos. 1988. A nosocomial outbreak of Branhamella catarrtalis confirmed by restriction endonuclease analysis. J. Infect. Dis. 157:996-1001.
137. Picard, B., P. Goullet, E. Denamur. and G. Suerdmondt. 1989. Esterase electrophoresis: a molecular tool for studying the epidemiology of Branhamella catarrhalis nosocomial infection. Epidemiol. Infect. 103:547-554.
138. Pittman, M. 1931. Variation and type specificity in the bacterial species Haemophilia influenzae. J. Exp. Med. 53:471-492.
139. Pollard, J. A., R. J. Wallace, Jr., D. R. Nash, J. I. Luman, and R. W. Wilson. 1986. Incidence of Branhamella catarrhalis in the sputa of patients with chronic lung disease. Drugs 31(3): 103-108.
140. Post, J. C., R. A. Preston, J. J. Aul, M. Larkins-Pettigrew, J. Rydquist, White, K. W. Anderson, R. M. Wadowsky, D. R. Reagan, E. S. Walker, L.A. Kingsley, A. E. Magit, and G. D. Ehrlich. 1995. Molecular analysis of bacterial pathogens in otitis media with effusion. JAMA 273:1598-1504
141. Prallet, B., F. Lucht, and C. Alexandre. 1991. Vertebral osteomyelitis due to Branhamella catarrhalis. Rev. Infect. Dis. 13:769.
142. Prellner, K., P. Christensen, B. Hovelius, and C. Rosen. 1984. Nasopharyngeal carriage of bacteria in otitis-prone and non-otitis-prone children in day-care centres. Acta Otolaryngol. 98:343-350.
143. Pukander, J. S., J. P. Jero, E. A. Kaprio, and M. J. Sorri. 1993. Clarithromycin vs. amoxicillin suspensions in the treatment of pediatric patients with acute otitis media. Pediatr. Infect. Dis. J. 12:S118-S12I.
144. Relman, D. A., M. Domenighini, E. Tuomanen, R. Rappuoli, and S. Falkow, 1989. Filamentous hemagglutinin of Bordetella pertussis: nucleotide sequence and crucial role of adherence. Proc. Natl. Acad. Sci. USA 86:2637-2641.
145. Richards, S. J., A. P. Greening, M. C. Enright, M. G. Morgan, and H. McKenzie. 1993. Outbreak of Moraxella catarrhalis in a respiratory unit. Thorax 48:91-92.
146. Rikitomi, N., B. Andersson, K. Matsumoto, R. Lindstedt, and C. Svanborg, 1991. Mechanism of adherence of Moraxella (Branhamella) catarrhalis. Scand. J. Infect. Dis. 23:559-567.
147. Robert, M. C., Y. Pang, R. C. Spencer, T. G. Winstanley, B. A. Brown, and R. J. Wallace, Jr. 1991. Tetracycline resistance in Moraxella (Branhamella) catarrhalis: demonstration of two clonal outbreaks by using pulsed-field gel electrophoresis. Antimicrob. Agents Chemother. 35:2453-2455.
148. Rotta, A. T., and B. I. Asmar. 1994. Moraxella catarrhalis bacteremia and preseptal cellulitis. South. Med. J. 87:541-542.
149. Ruuskanen, O., and T. Heikkinen. 1994. Otitis media: etiology and diagnosis. Pediatr. Infect. Dis. J. 13:S23-S26.
150. Sanyal, S. K., N. Wilson, K. Twum-Danso, A. Abomelha, and S. Sohel. 1990. Moraxella endocarditis following balloon angioplasty of aortic coarctation. Am. Heart J. 119:1421-1423.
151. Sarwar, J., A. A. Campagnari, C. Kirkham, and T. F. Murphy. 1992. Characterization of an antigenically conserved heat-modifiable major outer membrane protein of Branhamella catarrhalis. Infect. Immun. 60:804-809.
152. Sethi, S., S. L. Hill, and T. F. Murphy. 1995. Serum antibodies to outer membrane proteins of Moraxella (Branhamella) catarrhalis in patients with bronchiectasis: identification of OMP B1 as an important antigen. Infect. Immun. 63:1516-1520.
153. Shurin, P. A., S. I. Pelton, I. B. Tager, and D. L. Kasper. 1980 Bactericidal antibody and susceptibility to otitis media caused by nontypeable strains of Haemophilus influenzae. J. Pediatr. 97:364-369.
154. Shurin, P. A., J. M. Rehmus, C. E. Johnson, C. D. Marchant. S. A. Carlin, D. M. Super, G. F. Van Hare, P. K. Jones, D. M. Ambrosino, and G. R Siber. 1993. Bacterial polysaccharide immune globulin for prophylaxis of acute otitis media in high-risk children. J. Pediatr. 123:801-810.
155. Smith, G. L. 1987. Branhamella catarrhalis infection imitating gonorrhea in a man. N. Engl. J. Med. 316:1277.
156. Smith, J. M. B., and B. M. Lockwood. 1986. A 2-year survey of Branhamella catarrhalis in a general hospital. J. Hosp. Infect. 7:277-282.
157. Soto-Hernandez, J. L., S. Holtsclaw-Berk, L. M. Harvill, and S. L. Bert. 1989. Phenotypic characteristics of Branhamella catarrhalis strains. J. Clin. Microbiol. 27:903-908.
158. Srikumar, R., D. Dahan, M. F. Gras, M. J. H. Ratcliffe, L. van Alphea, and J. W. Coulton. 1992. Antigenic sites on porin of Haemophilia influence type b: mapping with synthetic peptides and evaluation of structure predictions. J. Bacteriol. 174:4007-4016.
159. Srinivasan, G., M. J. Raff, W. C. Templeton, S. J. Givens, R. C. Graves, and J. C. Melo. 1981. Branhamella catarrhalis pneumonia. Report of two cases and review of the literature. Am. Rev. Respir. Dis. 123:553-555.
160. Stenfors, L.-E., and S. Raisanen. 1990. Quantitative analysis of the bacterial findings in otitis media. J. Laryngol. Otol. 104:749-757.
161. Stenfors, L.-E., and S. Raisanen. 1992. Abundant attachment of bacteria to nasopharyngeal epithelium in otitis-prone children. J. Infect. Dis. 165:1148-1150.
162. Stenfors, L.-E., and S. Raisanen. 1993. Secretory IgA-, IgG- and C3b-coated bacteria in the nasopharynx of otitis-prone and non-otitis-prone children. Acta Otolaryngol. 113:191-195.
163. St. Geme, J. W., III, S. Falkow, and S. J. Barenkamp. 1993. High-molecular-weight proteins of nontypable Haemophilus influenzae mediate attachment to human epithelial cells. Proc. Natl. Acad. Sci. USA 90:2875-2879.
164. Stool, S. E., and M. J. Field. 1989. The impact of otitis media. Pediatr Infect. Dis. J. 8:S11-S14.
165. Suzuki, K., and L. O. Bakaletz. 1994. Synergistic effect of adenovirus type 1 and nontypeable Haemophilus influenzae in a chinchilla model of experimental otitis media. Infect. Immun. 62:1710-1718.
166. Tuomanen, E., and A. Weiss. 1985. Characterization of two adhesins of Bodetella pertussis for human ciliated respiratory-epithelial cells. J. Infect. Dis. 152:118-125.
167. Ueyama, T., Y. Kurono, K. Shirabe, M. Takeshita, and G. Mogi. 1995. High incidence of Haemophilus influenzae in nasopharyngeal secretions and middle ear effusions as detected by PCR. J. Clin. Microbiol. 33:1835-1838.
168. Unhanand, M., I. Maciver, O. Ramilo, O. Arencibia-Mireles, J. C. Argyle, G. H. McCracken, Jr., and E. J. Hansen. 1992. Pulmonary clearance of Moraxella catarrhalis in an animal model. J. infect. Dis. 165:644-650.
169. Urisu, A., J. L. Cowell, and C. R. Manclark. 1986. Filamentous hemagglutinin has a major role in mediating adherence of Bordetella pertussis to human WiDr cells. Infect. Immun. 52:695-701.
170. Vaneechoutte, M., G. Verschraegen, G. Claeys, and A. M. Van Den Abeele. 1990. Serological typing of Branhamella catarrhalis strains on the basis of lipopolysaccharide antigens. J. Clin. Microbiol. 28:182-187.
171. Vaneechoutte, M., G. Verschraegen, G. Claeys, B. Weise, and A. M. Van Den Abeele. 1990. Respiratory tract carrier rates of Moraxella (BranhamelIa) catarrhalis in adults and children and interpretation of the isolation of M. catarrhalis from sputum. J. Clin. Microbiol. 28:2674-2680.
172. Van Hare, G. F., P. A. Shurin, C. D. Marchant, N. A. Cartelli, C. E. Johnson, D. Fulton, S. Carlin, and C. H. Kim. 1987. Acute otitis media caused by Branhemella catarrhalis: biology and therapy. Rev. Infect. Dis. 9:16-27.
173. Verduin, C. M., H. S. Bootsma, J. Hol, A. Fleer, M. Jansze, K. L. Klingman, T. F. Murphy, and H. Van Dijk. 1995. Complement resistance in Moraxella (Branhamella) catarrhalis is mediated by high-molecular-weight outer membrane protein (HMW-OMP), abstr. B-137, p. 189. In Abstracts of the 95th General Meeting of the American Society for Microbiology 1995. American Society for Microbiology, Washington, D.C.
174. Verduin, C. M., M. Jansze, C. Hol, T. E. Mollnes, J. Verhoef, and H. Van Dijk. 1994. Differences in complement activation between complement-resistant and complement-sensitive Moraxella (Branhamella) catarrhalis strains occur at the level of membrane attack complex formation. Infect. Immun. 62:589-595.
175. Verghese, A., E. Berro, J. Berro, and B. W. Franzus. 1990. Pulmonary clearance and phagocytic cell response in a murine model of Branhamella catarrhalis infection. J. Infect. Dis. 162:1189-1192.
176. Verghese, A., D. Roberson, J. H. Kalbfleisch, and F. Sarubbi. 1990. Randomized comparative study of cefixime versus cephalexin in acute bacterial exacerbations of chronic bronchitis. Antimicrob. Agents Chemother. 34: 1041-1044.
177. Verheul, A. F. M., H. Snippe, and J. T. Poolman. 1993. Meningucoccal lipopolysaccharides: virulence factor and potential vaccine component. Microbiol Rev. 57:34-49.
178. Vernham, G. A., and J. A. Crowther. 1993. Acute myeloid leukaemia presenting with acute Branhamella catarrhalis epiglottitis. J. Infect. 26:93-95.
179. Virolainen, A., P. Salo, J. Jero, P. Karma, J. Eskola, and M. Leinonen. 1994. Comparison of PCR assay with bacterial culture for detecting Streptococcus pneumoniae in middle ear fluid of children with acute otitis media. J. Clin. Microbiol. 32:2667-2670.
180. von Graevenitz, A., and R. R. Rathbone. 1981. Branhamella catarrhalis in respiratory secretions: clinical correlation in 16 cases. South. Med. J. 74: 1095-1096.
181. Wald, E. R., J. S. Reilly, M. Casselbrant, J. Ledesma-Medina, G. J. Milmoe, C. D. Bluestone, and D. Chiponis. 1984. Treatment of acute maxillary sinusitis in childhood: a comparative study of amoxicillin and cefaclor. J. Pediatr. 104:297-302.
182. Wallace, M. R., and E. C. Oldtield III. 1990. Moraxella (Branhamella) catarrhulis bacteremia. Arch. Intern. Med. 150:1332-1334.
183. Weiser, J. N. 1992. The oligosaccharide of Haemophilus influenzas. Microb. Pathog. 13:335-342.
184. Weiss, M. S., U. Abele, J. Weckesser, W. Welte, E. Schlitz, and G. E. Schulz. 1991. Molecular architecture and electrostatic properties of a bacterial porin. Science 254:1627-1630.
185. West, M., S. L. Berk, and J. K. Smith. 1982. Branhamella catarrhalis pneumonia. South. Med. J. 75:1021-1023.
186. Wright, P. W., and R. J. Wallace, Jr. 1989. Pneumonia due to Moraxella (Branhamella) catarrhalis. Semin. Respir. Infect. 4:40-46.
187. Yu, R., and A. B, Schryvers. 1993. The interaction between human transferrin and transferrin binding protein 2 from Moraxella (Branhamella) catarrhalis differs from that of other human pathogens. Microb. Pathog. 15: 433-445.